Anzemet

In the US, Anzemet (dolasetron systemic) is a member of the drug class 5HT3 receptor antagonists and is used to treat Nausea/Vomiting - Chemotherapy Induced and Nausea/Vomiting - Postoperative.

US matches:

• Anzemet


• Anzemet Tablets


• Anzemet Injection

Ingredient matches for Anzemet

Dolasetron

Dolasetron mesilate (a derivative of Dolasetron) is reported as an ingredient of Anzemet in the following countries:

• Australia


• Brazil


• Canada


• France


• Greece


• Italy


• Luxembourg


• Malta


• Mexico


• Poland


• Romania


• Tunisia


• United States


• Venezuela

Dolasetron mesilate monohydrate (a derivative of Dolasetron) is reported as an ingredient of Anzemet in the following countries:

• Switzerland


• United States

International Drug Name Search